Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis

Journal of the American Academy of Dermatology

Volumn 51, Issue 4, 2004, Pages 526-533

  Papakonstantinou, Eleni ^a   Dionyssopoulos, Alexander ^a   Aletras, Alexios J ^a   Pesintzaki, Chrisanthi ^a   Minas, Aristippos ^a   Karakiulakis, George ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

4 aminophenylmercuric acetate; APMA; base pair; bp; ECM; ELISA; enzyme linked immunosorbent assay; extracellular matrix; matrix metalloproteinase; membrane bound type matrix metalloproteinases; messenger RNA; MMP; mRNA; MT MMPs; PCR; polymerase chain reaction; RT

Indexed keywords

COLLAGENASE; COLLAGENASE 3; GELATIN; GELATINASE; GELATINASE B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HAMARTOMA; HEMANGIOFIBROMA; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN DEFECT; TUBEROUS SCLEROSIS; ZYMOGRAPHY;

ADULT; COLLAGENASES; GELATINASES; GENE EXPRESSION; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; SKIN; TISSUE EXTRACTS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES; TUBEROUS SCLEROSIS;

EID: 4644336910     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.01.055     Document Type: Article

References (25)

1. Gomez M., Sampson J., Whittemore V. The tuberous sclerosis complex. 1999;Oxford University Press, Oxford
2. van Slegtenhorst M., de Hoogt R., Hermans C., Nellist M., Janssen B., Verhoef S., et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science. 277:1997;805-808
3. Hengstschlager M., Rodman D.M., Miloloza A., Hengstschlager-Ottnad E., Rosner M., Kubista M. Tuberous sclerosis gene products in proliferation control. Mutat Res. 488:2001;233-239
4. Tapon N., Ito N., Dickson B.J., Treisman J.E., Hariharan I.K. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell. 105:2001;345-355
5. Dabora S.L., Jozwiak S., Franz D.N., Roberts P.S., Nieto A., Chung J., et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet. 68:2001;64-80
6. Curatolo P., Verdecchia M., Bombardieri R. Tuberous sclerosis complex: a review of neurological aspects. Eur J Pediatr Neurol. 6:2002;15-23
7. Arbiser J.L., Brat D., Hunter S., D'Armiento J., Henske E.P., Arbiser Z.K., et al. Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms. J Am Acad Dermatol. 46:2002;376-380
8. Sogut A., Ozmen M., Sencer S., Caliskan M., Aydinli N., Ertugrul T., et al. Clinical features of tuberous sclerosis cases. Turk J Pediatr. 44:2002;98-101
9. Bittencourt R.C., Huilgol S.C., Seed P.T., Calonje E., Markey A.C., Barlow R.J. Treatment of angiofibromas with a scanning carbon dioxide laser: a clinicopathologic study with long-term follow-up. J Am Acad Dermatol. 45:2001;731-735
10. Kerkela E., Saarialho-Kere U. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol. 12:2003;109-125
11. Fischer M.H., Fortune J.S., Foster S.H., Gilbert E.F. Chemical analysis of an angiofibroma from a patient with tuberous sclerosis. J Ment Defic Res. 21:1977;251-261
12. Konomi H., Arima M., Tanaka H., Nagai Y. Immunohistochemical and biochemical studies on collagen types in angiofibromas and shagreen patches from patients with tuberous sclerosis. Brain Dev. 4:1982;367-374
13. Oikarinen A., Palatsi R., Linna S.L., Peltonen L. Types I and III collagens and the activities of prolyl hydroxylase and galactosylhydroxylysyl glucosyltransferase in skin lesions of tuberous sclerosis. Br J Dermatol. 107:1982;659-664
14. Karakiulakis G., Papanikolaou C., Jankovic S.M., Aletras A., Papakonstantinou E., Vretou E., et al. Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon. Invasion Metastasis. 17:1997;158-168
15. Syggelos S.A., Eleftheriou S.C., Giannopoulou E., Panagiotopoulos E., Aletras A.J. Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses. J Rheumatol. 28:2001;1319-1329
16. Giambernardi T.A., Grant G.M., Taylor G.P., Hay R.J., Maher V.M., McCormick J.J., et al. Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol. 16:1998;483-496
17. Grant G.M., Giambernardi T.A., Grant A.M., Klebe R.J. Overview of expression of matrix metalloproteinases (MMP-17, MMP-18, and MMP-20) in cultured human cells. Matrix Biol. 18:1999;145-148
18. Triebel S., Blaser J., Gote T., Pelz G., Schuren E., Schmitt M., et al. Evidence for the tissue inhibitor of metalloproteinases-1 (TIMP-1) in human polymorphonuclear leukocytes. Eur J Biochem. 231:1995;714-719
19. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254
20. Maioli E., Fortino V., Torricelli C., Arezzini B., Gardi C. Effect of parathyroid hormone-related protein on fibroblast proliferation and collagen metabolism in human skin. Exp Dermatol. 11:2002;302-310
21. Sehgal I., Thompson T.C. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-β1 in human prostate cancer cell lines. Mol Biol Cell. 10:1999;407-416
22. Itoh Y., Binner S., Nagase H. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate. Biochem J. 308:1955;645-651
23. Hayakawa T., Yamashita K., Shinagawa A. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci. 107:1994;2372-2379
24. D'Armiento J. Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction. Trends Cardiovasc Med. 12:2002;97-101
25. Lemaitre V., O'Byrne T.K., Borczuk A.C., Okada Y., Tall A.R., D'Armiento J. ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J Clin Invest. 107:2001;1227-1234